Scientists claim that a cure for cancer is only a year away.
A team of Israeli scientists have had the breakthrough we have all been looking for, A complete cure for cancer! They say their cure will be effective from day 1.
It is a new treatment called MuTaTo, the treatment uses a combination of cancer specific targeting peptides and a cancer toxin that only kills cancer cells.
The company behind this radical new treatment is Accelerated Evolution Biotechnologies Ltd. They were founded back in 2000.
Chairman, Dan Aridor told The Jerusalem Post:
“We believe we will offer in a years time a complete cure for cancer. Our cancer cure will be effective from day one, will last a duration of a few weeks and will have no or minimal side-effects at a much lower cost than most other treatments on the market. Our solution will be both generic and personal.”
So what does MuTaTo stand for?
MuTaTo means Multi-Target toxin and will essentially be a cancer antibiotic CEO DR Ilan Morad claims.
The company initially started out doing what every other cancer company are doing, but soon
After their initial ‘same as everybody else’ trials, they started to identify why no other cancer drug was effective in killing cancer cells. They soon figured that part out and went on to produce a drug that countered that effect.
How did they figure out why other cancer drugs or treatment didn’t work?
Good question, first off they found that most anti-cancer drugs available only target 1 specific part of the cancer cell. This treatment fails because the cancer cells are clever and quickly mutate when being attacked, rendering the drug in effect, useless!
DR Morad insists his drug MuTaTo won’t fail in the way other cancer drugs do, as it uses a combination of cancer-killing peptides for each and every cancer cell at the same time, along with a strong peptide toxin cancer cells don’t stand a chance!
This state of the art cancer treatment breakthrough is not affected by cancer cells fighting back and mutating, because the MuTaTu treatment targets three specific areas of the cancer cell at the same time.
Dr Morad explains in a statement below:
“We made sure that the treatment will not be affected by mutations; cancer cells can mutate in such a way that targeted receptors are dropped by the cancer. The probability of having multiple mutations that would modify all targeted receptors simultamiously decreases dramatically with the number of targets used. Instead of attacking receptors one at a time, we attack receptors 3 at a time – noy even cancer can mutate three receptors at one time.”
Dr Ilam Morad
In effect these drugs can be tailored to a specific person and their needs reducing side effects to extremely minimal.
Human trails are needed now, but the study on mice has been extremely ground-breaking!
Say goodbye to the big C, were only a few years off! …Yipee!